Ani Pharmaceuticals (ANIP) Operating Expenses (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Operating Expenses of $198.6 million for Q1 2026, down 6.46% sequentially from $212.3 million in Q4 2025, and up 16.17% YoY from $170.9 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Operating Expenses (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Operating Expenses for 17 years, with the latest figure at $198.6 million in Q1 2026.
- Quarterly Operating Expenses rose 16.17% year-over-year to $198.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $799.9 million (up 19.82% YoY) and the FY2025 annual result came in at $772.3 million, up 25.82% from the prior year.
- Operating Expenses eased to $198.6 million in Q1 2026 per ANIP's latest filing, from $212.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $212.3 million in Q4 2025 and troughed at $83.7 million in Q1 2022.
- A 5-year average of $139.8 million and a median of $124.9 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 62.55% in 2022, then rose 8.9% in 2025.
- Over 5 years, Operating Expenses stood at $92.4 million in 2022, then surged by 35.19% to $124.9 million in 2023, then surged by 56.05% to $195.0 million in 2024, then advanced by 8.9% to $212.3 million in 2025, then fell by 6.46% to $198.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $198.6 million, $212.3 million, and $191.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 225.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225.58 Mn |
| Mar 31, 2026 | 198.57 Mn |
| Dec 31, 2025 | 212.29 Mn |
| Sep 30, 2025 | 191.57 Mn |
| Jun 30, 2025 | 197.48 Mn |
| Mar 31, 2025 | 170.93 Mn |
| Dec 31, 2024 | 194.95 Mn |
| Sep 30, 2024 | 168.85 Mn |
| Jun 30, 2024 | 132.87 Mn |
| Mar 31, 2024 | 117.12 Mn |
| Dec 31, 2023 | 124.93 Mn |
| Sep 30, 2023 | 113.88 Mn |
| Jun 30, 2023 | 104.15 Mn |
| Mar 31, 2023 | 96.89 Mn |
| Dec 31, 2022 | 92.41 Mn |
| Sep 30, 2022 | 88.82 Mn |
| Jun 30, 2022 | 86.77 Mn |
| Mar 31, 2022 | 83.67 Mn |
| Dec 31, 2021 | 84.65 Mn |
| Sep 30, 2021 | 55.62 Mn |